(Q43587787)

24 November 2017

Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey (English)

1 reference

24 November 2017

1 reference

5

1 reference

24 November 2017

Friedman DS

1

1 reference

24 November 2017

Katz J

series ordinal

2

1 reference

24 November 2017

Bressler NM

series ordinal

3

1 reference

24 November 2017

Rahmani B

series ordinal

4

1 reference

24 November 2017

1 June 1999

1 reference

24 November 2017

1 reference

24 November 2017

106

1 reference

24 November 2017

1049-1055

1 reference

24 November 2017

6

1 reference

Racial differences in the cause-specific prevalence of blindness in east Baltimore

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Blind registrations in Western Australia: a five-year study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Features of age-related macular degeneration in a black population. The Barbados Eye Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Blindness and visual impairment in an American urban population. The Baltimore Eye Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Standardized illumination for visual acuity testing in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

A Wilcoxon-type test for trend

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

The Barbados Eye Study. Prevalence of open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Race, macular degeneration, and the Macular Photocoagulation Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Choroidal neovascularization in black patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Symptomatic choroidal neovascularization in blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Senile macular degeneration: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990267-1

7 January 2021

10.1016/S0161-6420(99)90267-1

Identifiers

DOI

1 reference

24 November 2017

1 reference